Plerixafor Mobilization

Plerixafor Mobilization is a pharmacological stem cell mobilization strategy that involves the administration of plerixafor, a CXCR4 chemokine receptor antagonist, to disrupt the SDF-1α/CXCR4 axis and enhance the release of hematopoietic stem and progenitor cells from the bone marrow niche into peripheral circulation for subsequent apheresis collection.

204

Publications

9.1K

Citations

1.5K

Authors

578

Institutions

Publications per year

2017–2026

51

Publications

204

1–5 of 204

Authors

1.5K

  1. IN
    Ivana N. Micallef

    Mayo Clinic, United States

    13 publications · 2.1K citations

    13

    h-index

  2. JF
    John F. DiPersio

    Washington University in St. Louis, United States

    14 publications · 2.1K citations

    13

    h-index

  3. RT
    Richard T. Maziarz

    Oregon Health & Science University, United States

    11 publications · 2K citations

    11

    h-index

  4. EJ
    Esa Jantunen

    Kuopio University Hospital, Finland

    9 publications · 243 citations

    10

    h-index

  5. GC
    Gary Calandra

    United States Military Academy, United States

    10 publications · 1.5K citations

    10

    h-index

1–5 of 1.5K

Venues

  1. Bone Marrow Transplantation

    35 publications · 1.8K citations

    25

    h-index

  2. Transfusion

    27 publications · 812 citations

    19

    h-index

  3. Biology of Blood and Marrow Transplantation

    TCT · 27 publications · 1.4K citations

    17

    h-index

  4. Journal of Clinical Apheresis

    9 publications · 209 citations

    9

    h-index

  5. Leukemia & lymphoma/Leukemia and lymphoma

    8 publications · 153 citations

    8

    h-index

1–5